Two Sigma Investments
KERX

Two Sigma Investments’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Two Sigma Investments’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-23,295
Closed -$397K – 2458
2014
Q1 		$397K Sell
23,295
-9,347
-29% -$141K ﹤0.01% 1567
2013
Q4 		$423K Buy
32,642
+8,683
+36% +$104K ﹤0.01% 1737
2013
Q3 		$242K Buy
23,959
+1,377
+6% +$12.3K ﹤0.01% 1571
2013
Q2 		$169K Buy
+22,582
New +$176K ﹤0.01% 1811

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

Two Sigma Investments's KERX Position: Q2 2014 in Review

Two Sigma Investments sold out of Keryx Biopharmaceuticals Inc (KERX) in Q2 2014, closing a stake of 23,295 shares — an estimated $397K sold.

Two Sigma Investments first reported a position in KERX in Q2 2013 and held it in 4 quarters. The position peaked at $423K in Q4 2013. 135 funds tracked by Wall St. Rank hold KERX as of Q2 2014.

  • Two Sigma Investments reported no remaining Keryx Biopharmaceuticals Inc position as of Q2 2014 after selling out during the quarter.
  • Two Sigma Investments sold 23,295 Keryx Biopharmaceuticals Inc shares in Q2 2014, an estimated $397K.
  • Two Sigma Investments first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 4 quarters.
  • Two Sigma Investments's Keryx Biopharmaceuticals Inc position peaked at $423K in Q4 2013.
  • 135 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q2 2014.

Based on Two Sigma Investments's 13F filing for Q2 2014, filed 14 Aug 2014.